Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Apr;77(4):1201–1206. doi: 10.1172/JCI112422

Insulin action in human adipose tissue in acromegaly.

J Bolinder, J Ostman, S Werner, P Arner
PMCID: PMC424457  PMID: 3514677

Abstract

The mechanisms underlying insulin resistance in acromegaly were investigated. Adipose tissue was obtained from nine patients with acromegaly who had in vivo insulin resistance and from 14 matched healthy control subjects. Receptor binding and the antilipolytic effect of insulin were determined in isolated fat cells. Insulin-induced glucose oxidation at a physiological hexose concentration was investigated in fat segments. In fat cells obtained from acromegaly patients after an overnight fast, insulin binding at low hormone concentrations was significantly reduced by 20-30%, insulin-induced antilipolysis was unchanged, but glucose oxidation was unresponsive to insulin. Since it has recently been observed that glucose feeding may rapidly modify insulin action in human adipocytes, fat cells were also obtained 60 min after an 100-g oral glucose load. In this situation, insulin binding at low hormone concentrations was further reduced to one-half of that in the control group, and the sensitivity of insulin-induced antilipolysis was markedly decreased in acromegaly. It is concluded that, in the fasting state, the action of insulin on glucose utilization but not on lipolysis is impaired in adipose tissue of acromegalic patients because of a postreceptor defect. After glucose ingestion, the resistance to insulin in acromegaly is further enhanced and antilipolysis is also impaired. Altered coupling between receptor and effector alone or in combination with an additional decrease in receptor binding may explain the enhancement of insulin resistance. These mechanisms may be essential factors in the pathogenesis of insulin resistance in acromegaly.

Full text

PDF
1201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arner P., Arner O., Ostman J. The effect of local anaesthetic agents on lipolysis by human adipose tissue. Life Sci. 1973 Jul 16;13(2):161–169. doi: 10.1016/0024-3205(73)90191-4. [DOI] [PubMed] [Google Scholar]
  2. Arner P., Bolinder J., Engfeldt P., Hellmér J., Ostman J. Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion. J Clin Invest. 1984 Mar;73(3):673–680. doi: 10.1172/JCI111259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arner P., Bolinder J., Engfeldt P., Ostman J. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation. Metabolism. 1981 Aug;30(8):753–760. doi: 10.1016/0026-0495(81)90020-2. [DOI] [PubMed] [Google Scholar]
  4. Arner P., Bolinder J., Ostman J. Glucose stimulation of the antilipolytic effect of insulin in humans. Science. 1983 Jun 3;220(4601):1057–1059. doi: 10.1126/science.6342138. [DOI] [PubMed] [Google Scholar]
  5. Arner P., Bolinder J., Ostman J. Marked increase in insulin sensitivity of human fat cells 1 hour after glucose ingestion. J Clin Invest. 1983 Mar;71(3):709–714. doi: 10.1172/JCI110817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arner P., Ostman J. Mono-acid diacylglycerols in human adipose tissue. Biochim Biophys Acta. 1974 Nov 18;369(2):209–221. doi: 10.1016/0005-2760(74)90252-5. [DOI] [PubMed] [Google Scholar]
  7. Baxter R. C., Brown A. S., Turtle J. R. Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem. 1982 Mar;28(3):488–495. [PubMed] [Google Scholar]
  8. Beck-Nielsen H., Pedersen O., Kragballe K., Sorensen N. S. The monocyte as a model for the study of insulin receptors in man. Diabetologia. 1977 Dec;13(6):563–569. doi: 10.1007/BF01236308. [DOI] [PubMed] [Google Scholar]
  9. Beck P., Schalch D. S., Parker M. L., Kipnis D. M., Daughaday W. H. Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med. 1965 Sep;66(3):366–379. [PubMed] [Google Scholar]
  10. Björkhem I., Arner P., Thore A., Ostman J. Sensitive kinetic bioluminescent assay of glycerol release from human fat cells. J Lipid Res. 1981 Sep;22(7):1142–1147. [PubMed] [Google Scholar]
  11. Bolinder J., Ostman J., Arner P. Effects of intravenous and oral glucose administration on insulin action in human fat cells. Diabetes. 1985 Sep;34(9):884–890. doi: 10.2337/diab.34.9.884. [DOI] [PubMed] [Google Scholar]
  12. Bolinder J., Ostman J., Arner P. Postreceptor defects causing insulin resistance in normoinsulinemic non-insulin-dependent diabetes mellitus. Diabetes. 1982 Oct;31(10):911–916. doi: 10.2337/diab.31.10.911. [DOI] [PubMed] [Google Scholar]
  13. Bratusch-Marrain P. R., Smith D., DeFronzo R. A. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab. 1982 Nov;55(5):973–982. doi: 10.1210/jcem-55-5-973. [DOI] [PubMed] [Google Scholar]
  14. CERASI E., LUFT R. INSULIN RESPONSE TO GLUCOSE LOADING IN ACROMEGALY. Lancet. 1964 Oct 10;2(7363):769–771. doi: 10.1016/s0140-6736(64)90556-2. [DOI] [PubMed] [Google Scholar]
  15. Coburn H. J., Carroll J. J. Improved manual and automated colorimetric determination of serum glucose, with use of hexokinase and glucose-6-phosphate dehydrogenase. Clin Chem. 1973 Jan;19(1):127–130. [PubMed] [Google Scholar]
  16. Emmer M., Gorden P., Roth J. Diabetes in association with other endocrine disorders. Med Clin North Am. 1971 Jul;55(4):1057–1064. doi: 10.1016/s0025-7125(16)32498-1. [DOI] [PubMed] [Google Scholar]
  17. Gliemann J., Rees W. D., Foley J. A. The fate of labelled glucose molecules in the rat adipocyte. Dependence on glucose concentration. Biochim Biophys Acta. 1984 May 22;804(1):68–76. doi: 10.1016/0167-4889(84)90100-9. [DOI] [PubMed] [Google Scholar]
  18. Gries F. A., Steinke J. Comparative effects of insulin on adipose tissue segments and isolated fat cells of rat and man. J Clin Invest. 1967 Sep;46(9):1413–1421. doi: 10.1172/JCI105633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hirsch J., Gallian E. Methods for the determination of adipose cell size in man and animals. J Lipid Res. 1968 Jan;9(1):110–119. [PubMed] [Google Scholar]
  20. Ivanyi J., Davies P. Monoclonal antibodies against human growth hormone. Mol Immunol. 1980 Feb;17(2):287–290. doi: 10.1016/0161-5890(80)90082-6. [DOI] [PubMed] [Google Scholar]
  21. Kahn C. R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978 Dec;27(12 Suppl 2):1893–1902. doi: 10.1016/s0026-0495(78)80007-9. [DOI] [PubMed] [Google Scholar]
  22. Klotz I. M. Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science. 1982 Sep 24;217(4566):1247–1249. doi: 10.1126/science.6287580. [DOI] [PubMed] [Google Scholar]
  23. Muggeo M., Bar R. S., Roth J., Kahn C. R., Gorden P. The insulin resistance of acromegaly: evidence for two alterations in the insulin receptor on circulating monocytes. J Clin Endocrinol Metab. 1979 Jan;48(1):17–25. doi: 10.1210/jcem-48-1-17. [DOI] [PubMed] [Google Scholar]
  24. Muggeo M., Saviolakis G. A., Businaro V., Valerio A., Moghetti P., Crepaldi G. Insulin receptor on monocytes from patients with acromegaly and fasting hyperglycemia. J Clin Endocrinol Metab. 1983 Apr;56(4):733–738. doi: 10.1210/jcem-56-4-733. [DOI] [PubMed] [Google Scholar]
  25. Nyberg G., Boström S., Johansson R., Smith U. Reduced glucose incorporation to triglycerides following chronic exposure of human fat cells to growth hormone. Acta Endocrinol (Copenh) 1980 Sep;95(1):129–133. doi: 10.1530/acta.0.0950129. [DOI] [PubMed] [Google Scholar]
  26. Nyberg G., Smith U. Human adipose tissue in culture. VII. The long-term effect on growth hormone. Horm Metab Res. 1977 Jan;9(1):22–27. doi: 10.1055/s-0028-1093577. [DOI] [PubMed] [Google Scholar]
  27. Olefsky J. M. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes. 1981 Feb;30(2):148–162. doi: 10.2337/diab.30.2.148. [DOI] [PubMed] [Google Scholar]
  28. RODBELL M. METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem. 1964 Feb;239:375–380. [PubMed] [Google Scholar]
  29. Rizza R. A., Mandarino L. J., Gerich J. E. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes. 1982 Aug;31(8 Pt 1):663–669. doi: 10.2337/diab.31.8.663. [DOI] [PubMed] [Google Scholar]
  30. Sjöström L., Björntorp P., Vrána J. Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells. J Lipid Res. 1971 Sep;12(5):521–530. [PubMed] [Google Scholar]
  31. Taylor R., McCulloch A. J., Zeuzem S., Gray P., Clark F., Alberti K. G. Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Acta Endocrinol (Copenh) 1985 May;109(1):96–103. doi: 10.1530/acta.0.1090096. [DOI] [PubMed] [Google Scholar]
  32. YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zinder O., Shapiro B. Effect of cell size on epinephrine- and ACTH-induced fatty acid release from isolated fat cells. J Lipid Res. 1971 Jan;12(1):91–95. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES